Kiromic BioPharma Inc. (KRBP)
Kiromic BioPharma Statistics
Share Statistics
Kiromic BioPharma has 2.65M shares outstanding. The number of shares has increased by 20% in one year.
| Shares Outstanding | 2.65M |
| Shares Change (YoY) | 20% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 4.93% |
| Shares Floating | 1.93M |
| Failed to Deliver (FTD) Shares | 659 |
| FTD / Avg. Volume | 43.99% |
Short Selling Information
The latest short interest is 45.74K, so 2.98% of the outstanding shares have been sold short.
| Short Interest | 45.74K |
| Short % of Shares Out | 2.98% |
| Short % of Float | 4.09% |
| Short Ratio (days to cover) | 1.45 |
Valuation Ratios
The PE ratio is -0.87 and the forward PE ratio is -0.52. Kiromic BioPharma's PEG ratio is 0.01.
| PE Ratio | -0.87 |
| Forward PE | -0.52 |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | -1.86 |
| P/FCF Ratio | -1.18 |
| PEG Ratio | 0.01 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Kiromic BioPharma Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.16, with a Debt / Equity ratio of -1.16.
| Current Ratio | 0.16 |
| Quick Ratio | 0.16 |
| Debt / Equity | -1.16 |
| Total Debt / Capitalization | 735.39 |
| Cash Flow / Debt | -1.34 |
| Interest Coverage | 6.39 |
Financial Efficiency
Return on equity (ROE) is 2.14% and return on capital (ROIC) is -1200.1%.
| Return on Equity (ROE) | 2.14% |
| Return on Assets (ROA) | -3.15% |
| Return on Capital (ROIC) | -1200.1% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -611.32K |
| Employee Count | 44 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -36.44% in the last 52 weeks. The beta is 1.84, so Kiromic BioPharma's price volatility has been higher than the market average.
| Beta | 1.84 |
| 52-Week Price Change | -36.44% |
| 50-Day Moving Average | 1.12 |
| 200-Day Moving Average | 1.63 |
| Relative Strength Index (RSI) | 58.54 |
| Average Volume (20 Days) | 1.5K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -23.77M |
| Net Income | -26.9M |
| EBITDA | -23.77M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -1.03 |
Balance Sheet
The company has 1.14M in cash and 14.57M in debt, giving a net cash position of -13.43M.
| Cash & Cash Equivalents | 1.14M |
| Total Debt | 14.57M |
| Net Cash | -13.43M |
| Retained Earnings | -149.79M |
| Total Assets | 8.54M |
| Working Capital | -17.6M |
Cash Flow
In the last 12 months, operating cash flow was -19.46M and capital expenditures -366K, giving a free cash flow of -19.82M.
| Operating Cash Flow | -19.46M |
| Capital Expenditures | -366K |
| Free Cash Flow | -19.82M |
| FCF Per Share | -0.76 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
KRBP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -68.67% |
| FCF Yield | -498.06% |
Analyst Forecast
Currently there are no analyst rating for KRBP.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Mar 13, 2023. It was a backward split with a ratio of 1:30.
| Last Split Date | Mar 13, 2023 |
| Split Type | backward |
| Split Ratio | 1:30 |
Scores
| Altman Z-Score | -35.85 |
| Piotroski F-Score | 2 |